Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results
Bullish near-term on solid revenue growth, robust cash flow, and reaffirmed 2026 guidance; monitor margin mix and M&A cadence.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish near-term on solid revenue growth, robust cash flow, and reaffirmed 2026 guidance; monitor margin mix and M&A cadence.
What happened and why it matters
Afya reported Q2 2026 revenue of R$972.1m, up 5.7% YoY, with Adjusted EBITDA of R$406.5m and net income of R$201.3m. 1H26 cash from operations reached R$805.6m on a solid balance sheet of R$1,006.5m cash, while management reaffirmed 2026 targets and highlighted shareholder returns of R$447.9m via dividends and buybacks. The firm also notes a robust ecosystem with nearly 295k users, signaling continued enrollment and cross-segment growth ahead.
The company delivered organic revenue growth, solid cash generation, and reaffirmed 2026 targets, all of which historically support share price upside. Positive near-term catalysts include Moody's rating confirmation and strong FCFE payout; risks include margin compression and regulatory/Acquisition execution risk (ENAMED, FUNIC).
2Q26 revenue 972.1m R$; YoY +5.7% (5.4% organic).
Adjusted EBITDA 406.5m R$; margin 41.8% (down 180bps).
1H26 revenue 1,984.8m R$; Free Cash Flow to Equity yield 11%.
Guidance reaffirmed: 2026 revenue 3.95–4.10b; EBITDA 1.70–1.80b; CAPEX 340–380m.
Moody's AAA.br reaffirmation; robust liquidity; ecosystem users ~295k.
Category: Earnings. The release centers on quarterly earnings, guidance reaffirmation, and capital allocation specifics, fitting typical investor-communications for an education/healthcare services group with Brazil exposure.
More AI-analyzed coverage connected to this story